Related Experiment Video
Updated: Aug 28, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer
Yuri Tolkach1,2, Anika Kremer1, Gábor Lotz3
1Institute of Pathology, University Hospital Bonn, 53127 Bonn, Germany.
Background:
Canonical androgen receptor (AR) signaling regulates a network of DNA repair genes in prostate cancer (PCA). Experimental and clinical evidence indicates that androgen deprivation not only suppresses DNA repair activity but is often synthetically lethal in combination with PARP inhibition. The present study aimed to elucidate the impact of AR splice variants (AR-Vs), occurring in advanced or late-stage PCA, on DNA repair machinery.
Methods:
Two hundred and seventy-three tissue samples were analyzed, including primary hormone-naïve PCA, primary metastases, hormone-sensitive PCA on androgen deprivation therapy (ADT) and castration refractory PCA (CRPC group). The transcript levels of the target genes were profiled using the nCounter platform. Experimental support for the findings was gained in AR/AR-V7-expressing LNCaP cells subjected to ionizing radiation.
Results:
AR-Vs were present in half of hormone-sensitive PCAs on androgen deprivation therapy (ADT) and two-thirds of CRPC samples. The presence of AR-Vs is highly correlated with increased activity in the AR pathway and DNA repair gene expression. In AR-V-expressing CRPC, the DNA repair score increased by 2.5-fold as compared to AR-V-negative samples. Enhanced DNA repair and the deregulation of DNA repair genes by AR-V7 supported the clinical data in a cell line model.
Conclusions:
The expression of AR splice variants such as AR-V7 in PCA patients following ADT might be a reason for reduced or absent therapy effects in patients on additional PARP inhibition due to the modulation of DNA repair gene expression. Consequently, AR-Vs should be further studied as predictive biomarkers for therapy response in this setting.
Insights
Androgen receptor splice variants (AR-Vs) in prostate cancer (PCA) increase DNA repair activity. This may explain why PARP inhibition is less effective in patients with AR-Vs, suggesting AR-Vs as potential biomarkers for therapy response.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Canonical androgen receptor (AR) signaling influences DNA repair genes in prostate cancer (PCA).
- Androgen deprivation therapy (ADT) can suppress DNA repair and create synthetic lethality with PARP inhibition.
- AR splice variants (AR-Vs) are prevalent in advanced PCA and may alter DNA repair.
Purpose of the Study:
- To investigate the impact of AR splice variants (AR-Vs) on DNA repair machinery in prostate cancer.
- To correlate AR-V expression with AR pathway activity and DNA repair gene expression.
- To evaluate the role of AR-Vs in therapeutic response, particularly with PARP inhibition.
Main Methods:
- Analysis of 273 prostate cancer tissue samples (hormone-naïve, metastatic, ADT-treated, castration-refractory PCA).
- Profiling of target gene transcript levels using the nCounter platform.
- Experimental validation in AR/AR-V7-expressing LNCaP cells subjected to ionizing radiation.
Main Results:
- AR-Vs were detected in 50% of ADT-treated PCAs and 67% of castration-refractory PCAs (CRPCs).
- AR-V presence strongly correlated with heightened AR pathway activity and DNA repair gene expression.
- AR-V-expressing CRPCs showed a 2.5-fold increase in DNA repair scores compared to AR-V-negative samples.
Conclusions:
- AR splice variants, like AR-V7, in prostate cancer patients undergoing ADT may reduce the efficacy of PARP inhibition by modulating DNA repair gene expression.
- AR-Vs could be responsible for diminished or absent therapeutic effects in patients receiving PARP inhibitors.
- AR-Vs warrant further investigation as predictive biomarkers for therapy response in prostate cancer.
Related Concept Videos
RNA Splicing
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Overview of DNA Repair
DNA Damage can Stall the Cell Cycle
Epigenetic Regulation
X-chromosome...

